Literature DB >> 22311048

Cell cycle arrest and apoptosis by expression of a novel TPIP (TPIP-C2) cDNA encoding a C2-domain in HEK-293 cells.

Rasmi Rekha Mishra1, Jitendra Kumar Chaudhary, Pramod C Rath.   

Abstract

The human TPIP (TPTE and PTEN homologous Inositol lipid Phosphatase) belongs to the PTEN (Phosphatase and TENsin homologue deleted on chromosome 10) family of dual-specific phosphatases and is expressed from the human chromosome 13 as multiple splice-variants, e.g., TPIPα, β, γ mRNAs. PTEN is a well characterized tumor suppressor, which controls survival, adhesion, motility and migration of mammalian cells, its C2-domain plays crucial role in controlling these functions. However, role of isolated C2-domain protein in regulation of cell proliferation and apoptosis is not reported. We report sequence analysis and function of a novel human TPIP (TPIP-C2) cDNA encoding a 193 amino acid C2-domain in cell proliferation and apoptosis regulation. In silico analysis and homology modelling revealed that the C2-domain of TPIP-C2 is similar to that of PTEN but with short disorder sequences overlapping or adjacent to the post-translational modification sites. Overexpression of TPIP-C2 cDNA in human embryonic kidney (HEK-293) cells caused cell cycle arrest, inhibition of cell proliferation and induced apoptosis in an activated caspase 3 and PARP-dependent manner in comparison to overexpression of the full length human PTEN cDNA. TPIP-C2 overexpressed cells also showed S-phase cell cycle arrest. We suggest that C2-domain of TPIP-C2 may act as a dominant negative effector, which may bind to and arrest the cell proliferation signalling complex and isolated TPIP-C2-domain-like proteins expressed in mammalian cells/tissues may play important role in regulation of cell proliferation and apoptosis. The TPIP-C2 cDNA may be exploited for inducing cell cycle-inhibition and apoptosis in human cancer cells and tissues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311048     DOI: 10.1007/s11033-012-1571-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  40 in total

1.  Phosphorylation of the PTEN tail regulates protein stability and function.

Authors:  F Vazquez; S Ramaswamy; N Nakamura; W R Sellers
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  SuperPose: a simple server for sophisticated structural superposition.

Authors:  Rajarshi Maiti; Gary H Van Domselaar; Haiyan Zhang; David S Wishart
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

3.  PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation.

Authors:  J-J Lee; B C Kim; M-J Park; Y-S Lee; Y-N Kim; B L Lee; J-S Lee
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

4.  Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.

Authors:  M M Georgescu; K H Kirsch; P Kaloudis; H Yang; N P Pavletich; H Hanafusa
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

5.  TPIP: a novel phosphoinositide 3-phosphatase.

Authors:  S M Walker; C P Downes; N R Leslie
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

6.  Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding.

Authors:  N B Adey; L Huang; P A Ormonde; M L Baumgard; R Pero; D V Byreddy; S V Tavtigian; P L Bartel
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

7.  Pivotal role of the C2 domain of the Smurf1 ubiquitin ligase in substrate selection.

Authors:  Kefeng Lu; Ping Li; Minghua Zhang; Guichun Xing; Xin Li; Weihong Zhou; Mark Bartlam; Lingqiang Zhang; Zihe Rao; Fuchu He
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

8.  Inhibition of U6 snRNA Transcription by PTEN.

Authors:  Stephanie Cabarcas; Kounosuke Watabe; Laura Schramm
Journal:  Online J Biol Sci       Date:  2010-09-30

9.  Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity.

Authors:  Emmanuelle J Meuillet; Daruka Mahadevan; Margareta Berggren; Amy Coon; Garth Powis
Journal:  Arch Biochem Biophys       Date:  2004-09-15       Impact factor: 4.013

10.  Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain.

Authors:  Leticia Odriozola; Gobind Singh; Thuong Hoang; Andrew M Chan
Journal:  J Biol Chem       Date:  2007-06-12       Impact factor: 5.157

View more
  5 in total

1.  Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data.

Authors:  Runjun D Kumar; Li-Wei Chang; Matthew J Ellis; Ron Bose
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

2.  Microgrooved-surface topography enhances cellular division and proliferation of mouse bone marrow-derived mesenchymal stem cells.

Authors:  Jitendra Kumar Chaudhary; Pramod C Rath
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

Review 3.  Phosphatidylinositolphosphate phosphatase activities and cancer.

Authors:  Simon A Rudge; Michael J O Wakelam
Journal:  J Lipid Res       Date:  2015-08-24       Impact factor: 5.922

4.  Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma.

Authors:  Chanida Vinayanuwattikun; Florence Le Calvez-Kelm; Behnoush Abedi-Ardekani; David Zaridze; Anush Mukeria; Catherine Voegele; Maxime Vallée; Dewajani Purnomosari; Nathalie Forey; Geoffroy Durand; Graham Byrnes; James Mckay; Paul Brennan; Ghislaine Scelo
Journal:  Sci Rep       Date:  2016-08-22       Impact factor: 4.379

5.  Overexpressing TPTE2 (TPIP), a homolog of the human tumor suppressor gene PTEN, rescues the abnormal phenotype of the PTEN-/- mutant.

Authors:  Daniel F Lusche; Emma C Buchele; Kanoe B Russell; Benjamin A Soll; Michele I Vitolo; Michael R Klemme; Deborah J Wessels; David R Soll
Journal:  Oncotarget       Date:  2018-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.